270 related articles for article (PubMed ID: 26392377)
21. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.
Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP
Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738
[TBL] [Abstract][Full Text] [Related]
22. Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression.
Nakazawa Y; Suzuki M; Manabe N; Yamada T; Kihara-Negishi F; Sakurai T; Tenen DG; Iwama A; Mochizuki M; Oikawa T
Oncogene; 2007 May; 26(24):3541-50. PubMed ID: 17213822
[TBL] [Abstract][Full Text] [Related]
23. ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.
Tomar S; Plotnik JP; Haley J; Scantland J; Dasari S; Sheikh Z; Emerson R; Lenz D; Hollenhorst PC; Mitra AK
Cancer Lett; 2018 Feb; 414():190-204. PubMed ID: 29174800
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
[TBL] [Abstract][Full Text] [Related]
25. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
[TBL] [Abstract][Full Text] [Related]
26. Ets1 is an effector of protein kinase Calpha in cancer cells.
Vetter M; Blumenthal SG; Lindemann RK; Manns J; Wesselborg S; Thomssen C; Dittmer J
Oncogene; 2005 Jan; 24(4):650-61. PubMed ID: 15531915
[TBL] [Abstract][Full Text] [Related]
27. c-Ets1 is a promising marker in epithelial ovarian cancer.
Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
Int J Mol Med; 2002 Mar; 9(3):287-92. PubMed ID: 11836635
[TBL] [Abstract][Full Text] [Related]
28. A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions.
Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Uchiyama A; Baba S; Sato K; Yamamoto M; Ogata K
J Mol Biol; 2015 Apr; 427(8):1655-69. PubMed ID: 25083921
[TBL] [Abstract][Full Text] [Related]
29. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.
Fafeur V; Tulasne D; Quéva C; Vercamer C; Dimster V; Mattot V; Stéhelin D; Desbiens X; Vandenbunder B
Cell Growth Differ; 1997 Jun; 8(6):655-65. PubMed ID: 9185999
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.
John S; Russell L; Chin SS; Luo W; Oshima R; Garrett-Sinha LA
Mol Cell Biol; 2014 Feb; 34(3):522-32. PubMed ID: 24277931
[TBL] [Abstract][Full Text] [Related]
31. VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis.
Chen J; Fu Y; Day DS; Sun Y; Wang S; Liang X; Gu F; Zhang F; Stevens SM; Zhou P; Li K; Zhang Y; Lin RZ; Smith LEH; Zhang J; Sun K; Melero-Martin JM; Han Z; Park PJ; Zhang B; Pu WT
Nat Commun; 2017 Aug; 8(1):383. PubMed ID: 28851877
[TBL] [Abstract][Full Text] [Related]
32. miR‑200b upregulation promotes migration of BEAS‑2B cells following long‑term exposure to cigarette smoke by targeting ETS1.
Wang J; Yao R; Luo Q; Tan L; Jia B; Ouyang N; Li Y; Tong J; Li J
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109431
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of an intrinsically disordered region of Ets1 shifts a multi-modal interaction ensemble to an auto-inhibitory state.
Kasahara K; Shiina M; Higo J; Ogata K; Nakamura H
Nucleic Acids Res; 2018 Mar; 46(5):2243-2251. PubMed ID: 29309620
[TBL] [Abstract][Full Text] [Related]
34. RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
Hui K; Wu S; Yue Y; Gu Y; Guan B; Wang X; Hsieh JT; Chang LS; He D; Wu K
Cell Signal; 2018 Aug; 48():38-44. PubMed ID: 29702203
[TBL] [Abstract][Full Text] [Related]
35. miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
Li Z; Liu Z; Dong S; Zhang J; Tan J; Wang Y; Ge C; Li R; Xue Y; Li M; Wang W; Xiang X; Yang J; Ding H; Geng T; Yao K; Song X
Am J Pathol; 2015 Sep; 185(9):2412-20. PubMed ID: 26362716
[TBL] [Abstract][Full Text] [Related]
36. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model.
Pourtier-Manzanedo A; Vercamer C; Van Belle E; Mattot V; Mouquet F; Vandenbunder B
Oncogene; 2003 Mar; 22(12):1795-806. PubMed ID: 12660815
[TBL] [Abstract][Full Text] [Related]
37. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
Wernert N; Raes MB; Lassalle P; Dehouck MP; Gosselin B; Vandenbunder B; Stehelin D
Am J Pathol; 1992 Jan; 140(1):119-27. PubMed ID: 1370594
[TBL] [Abstract][Full Text] [Related]
38. The transcription factor ETS1 in lymphomas: friend or foe?
Testoni M; Chung EY; Priebe V; Bertoni F
Leuk Lymphoma; 2015 Jul; 56(7):1975-80. PubMed ID: 25363344
[TBL] [Abstract][Full Text] [Related]
39. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
40. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
